Search Results

Filter
  • 1-10 of  34 results for ""Attention Deficit Disorder with Hyperactivity drug therapy""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Azstarys (serdexmethylphenidate/dexmethylphenidate) for ADHD.

Subjects: Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/*drug therapy ; Central Nervous System Stimulants/Central Nervous System Stimulants/Central Nervous System Stimulants/*therapeutic use ; Methylphenidate/Methylphenidate/Methylphenidate/*therapeutic use

  • Source: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2021 Oct 04; Vol. 63 (1634), pp. 157-159.Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Viloxazine ER (Qelbree) for ADHD.

Subjects: Adolescent Behavior/Adolescent Behavior/Adolescent Behavior/*drug effects ; Adrenergic Uptake Inhibitors/Adrenergic Uptake Inhibitors/Adrenergic Uptake Inhibitors/*therapeutic use ; Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/*drug therapy

  • Source: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2021 Jun 28; Vol. 63 (1627), pp. 98-100.Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Drugs for ADHD.

Subjects: Adrenergic alpha-2 Receptor Agonists/Adrenergic alpha-2 Receptor Agonists/Adrenergic alpha-2 Receptor Agonists/*therapeutic use ; Amphetamines/Amphetamines/Amphetamines/*therapeutic use ; Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/*drug therapy

  • Source: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2020 Jan 27; Vol. 62 (1590), pp. 9-15.Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A new amphetamine oral suspension (Adzenys ER) for ADHD.

Subjects: Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/*drug therapy ; Central Nervous System Stimulants/Central Nervous System Stimulants/Central Nervous System Stimulants/*therapeutic use ; Lisdexamfetamine Dimesylate/Lisdexamfetamine Dimesylate/Lisdexamfetamine Dimesylate/*therapeutic use

  • Source: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2018 Jun 18; Vol. 60 (1549), pp. e106-e108. Date of Electronic Publication: 2018 Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Cotempla XR-ODT--another long-acting methylphenidate for ADHD.

Subjects: Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/*drug therapy ; Central Nervous System Stimulants/Central Nervous System Stimulants/Central Nervous System Stimulants/*therapeutic use ; Child Behavior/Child Behavior/Child Behavior/*drug effects

  • Source: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2017 Nov 06; Vol. 59 (1533), pp. 183-185.Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Two new amphetamines for ADHD.

Subjects: Amphetamine/Amphetamine/Amphetamine/*therapeutic use ; Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/*drug therapy ; Central Nervous System Stimulants/Central Nervous System Stimulants/Central Nervous System Stimulants/*therapeutic use

  • Source: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2016 Jun 20; Vol. 58 (1497), pp. 80-1.Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

QuilliChew ER--extended-release chewable methylphenidate tablets.

Subjects: Mastication*; Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/*drug therapy ; Central Nervous System Stimulants/Central Nervous System Stimulants/Central Nervous System Stimulants/*administration & dosage

  • Source: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2016 May 23; Vol. 58 (1495), pp. 68-9.Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Racemic amphetamine sulfate (Evekeo) for ADHD.

Subjects: Amphetamine/Amphetamine/Amphetamine/*chemistry ; Amphetamine/Amphetamine/Amphetamine/*therapeutic use ; Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/*drug therapy

  • Source: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2015 Sep 28; Vol. 57 (1478), pp. 137-8.Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  34 results for ""Attention Deficit Disorder with Hyperactivity drug therapy""